CELZ — Creative Medical Technology Holdings Cashflow Statement
0.000.00%
- $4.77m
- -$4.24m
- $0.01m
- 45
- 26
- 28
- 24
Annual cashflow statement for Creative Medical Technology Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -8.48 | -36.3 | 19.2 | -10.1 | -5.29 |
Amortisation | |||||
Non-Cash Items | 7.18 | 35.1 | -21.8 | 0.069 | 0.003 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 0.062 | 0.693 | 0.249 | 2.19 | -2.84 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Cash from Operating Activities | -1.21 | -0.435 | -2.22 | -7.8 | -8.03 |
Capital Expenditures | — | — | 0 | — | -0.1 |
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | — | -0.25 | — | -10.1 | 3.55 |
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | — | -0.25 | 0 | -10.1 | 3.45 |
Financing Cash Flow Items | — | — | -0.548 | 0 | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0.998 | 0.694 | 12.8 | 15.5 | -0.271 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -0.215 | 0.009 | 10.6 | -2.4 | -4.85 |